You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.
RabMAbs (1645-1)

Anti-Lyn (phospho Y396) antibody [EP503Y] (ab40660)

Publishing research using ab40660? Please let us know so that we can cite the reference in this datasheet.

ab40660 has been referenced in 7 publications.

  • Dai S  et al. Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis. PLoS Pathog 9:e1003114 (2013). WB ; Human . PubMed: 23359218
  • Hammadi M  et al. Membrane microdomain sphingolipids are required for anti-CD20-induced death of chronic lymphocytic leukemia B cells. Haematologica 97:288-96 (2012). WB ; Human . PubMed: 22058197
  • Ugarte-Berzal E  et al. A 17-residue Sequence from the Matrix Metalloproteinase-9 (MMP-9) Hemopexin Domain Binds a4ß1 Integrin and Inhibits MMP-9-induced Functions in Chronic Lymphocytic Leukemia B Cells. J Biol Chem 287:27601-13 (2012). WB ; Human . PubMed: 22730324
  • Fialin C  et al. The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors. Leukemia : (2012). PubMed: 22902361
  • Séïté JF  et al. IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes. Blood 116:1698-704 (2010). Flow Cyt ; Human . PubMed: 20516366
  • Kim SW  et al. Rational combined targeting of phosphodiesterase 4B and SYK in DLBCL. Blood 113:6153-60 (2009). WB ; Mouse . PubMed: 19369227
  • Wu J  et al. Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells. Blood 111:3821-9 (2008). WB ; Human . PubMed: 18235045

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"